Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

131 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The angiogenic switch leads to a metabolic shift in human glioblastoma.
Talasila KM, Røsland GV, Hagland HR, Eskilsson E, Flønes IH, Fritah S, Azuaje F, Atai N, Harter PN, Mittelbronn M, Andersen M, Joseph JV, Hossain JA, Vallar L, Noorden CJ, Niclou SP, Thorsen F, Tronstad KJ, Tzoulis C, Bjerkvig R, Miletic H. Talasila KM, et al. Among authors: niclou sp. Neuro Oncol. 2017 Mar 1;19(3):383-393. doi: 10.1093/neuonc/now175. Neuro Oncol. 2017. PMID: 27591677 Free PMC article.
Cell therapies for glioblastoma.
Terzis AJ, Niclou SP, Rajcevic U, Danzeisen C, Bjerkvig R. Terzis AJ, et al. Among authors: niclou sp. Expert Opin Biol Ther. 2006 Aug;6(8):739-49. doi: 10.1517/14712598.6.8.739. Expert Opin Biol Ther. 2006. PMID: 16856796 Review.
iTRAQ-based proteomics profiling reveals increased metabolic activity and cellular cross-talk in angiogenic compared with invasive glioblastoma phenotype.
Rajcevic U, Petersen K, Knol JC, Loos M, Bougnaud S, Klychnikov O, Li KW, Pham TV, Wang J, Miletic H, Peng Z, Bjerkvig R, Jimenez CR, Niclou SP. Rajcevic U, et al. Among authors: niclou sp. Mol Cell Proteomics. 2009 Nov;8(11):2595-612. doi: 10.1074/mcp.M900124-MCP200. Epub 2009 Aug 12. Mol Cell Proteomics. 2009. PMID: 19674965 Free PMC article.
Cancer stem cells and angiogenesis.
Bjerkvig R, Johansson M, Miletic H, Niclou SP. Bjerkvig R, et al. Among authors: niclou sp. Semin Cancer Biol. 2009 Oct;19(5):279-84. doi: 10.1016/j.semcancer.2009.09.001. Epub 2009 Oct 7. Semin Cancer Biol. 2009. PMID: 19818406 Review.
Anti-VEGF treatment reduces blood supply and increases tumor cell invasion in glioblastoma.
Keunen O, Johansson M, Oudin A, Sanzey M, Rahim SA, Fack F, Thorsen F, Taxt T, Bartos M, Jirik R, Miletic H, Wang J, Stieber D, Stuhr L, Moen I, Rygh CB, Bjerkvig R, Niclou SP. Keunen O, et al. Among authors: niclou sp. Proc Natl Acad Sci U S A. 2011 Mar 1;108(9):3749-54. doi: 10.1073/pnas.1014480108. Epub 2011 Feb 14. Proc Natl Acad Sci U S A. 2011. PMID: 21321221 Free PMC article.
Novel ways to target brain tumour metabolism.
Stieber D, Abdul Rahim SA, Niclou SP. Stieber D, et al. Among authors: niclou sp. Expert Opin Ther Targets. 2011 Oct;15(10):1227-39. doi: 10.1517/14728222.2011.588211. Epub 2011 Jun 2. Expert Opin Ther Targets. 2011. PMID: 21635150 Review.
In vivo models of primary brain tumors: pitfalls and perspectives.
Huszthy PC, Daphu I, Niclou SP, Stieber D, Nigro JM, Sakariassen PØ, Miletic H, Thorsen F, Bjerkvig R. Huszthy PC, et al. Among authors: niclou sp. Neuro Oncol. 2012 Aug;14(8):979-93. doi: 10.1093/neuonc/nos135. Epub 2012 Jun 7. Neuro Oncol. 2012. PMID: 22679124 Free PMC article. Review.
131 results